Abstract Title: currently loading...

information currently loading...

Loading ... please wait
timer Loading ... please wait

Free Paper Session 2: Quick Fire Free Paper

10:35 - 11:35 | 20 March | Room: ALFA Lecture Hall

Back to Previous

10:35 Cone density, cone mosaic and fundus autofluorescence results in focal laser-treated central serous chorioretinopathy
R. Ochinciuc Romania
10:40 Choroidal vascularity index in eyes with retinitis pigmentosa and cystoid macular edema
C. Iovino Italy
10:45 Influence of the foveal curvature on myopic macular complications
H.G. Yu South Korea
10:50 Comparing the efficacy of Aflibercept and Ranibizumab for the treatment of moderate to severe neovascular age related macular degeneration.
M. Ibrahimi UK
10:55 Identification of missense variants in SSBP1 expands the autosomal dominant optic atrophy phenotype: From primary retinal ganglion cells dysfunction and optic atrophy to retinal dystrophy
N. Jurkute UK
11:00 Subretinal drusenoid deposits and photoreceptor loss detecting global and local progression of geographic atrophy by SD-OCT imaging
G. Reiter Austria
11:05 Using 3D-MRI imaging to quantitatively analyze the shape of eyeballs with high myopia and to investigate relationships between myopic traction maculopathy and posterior staphyloma
X. Chen China
11:10 Histological characterization of sodium iodate-induced pathology in rats as a useful model for assessing therapeutic efficacy in age-related macular degeneration
I. Etienne Belgium
11:15 Diabetic retinopathy and cognitive impairment in type 1 diabetes patients: Is there a connection?
M. Lindziute Lithuania
11:20 Real-world outcomes of Aflibercept treatment for diabetic macular edema
U. Skirmantaite Lithuania
11:25 Simultaneous neutralization of angiopoietin-2 (ANG-2) and vascular endothelial growth factor-a (VEGF-A) with Faricimab: A review of the phase 2 clinical trials in neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME)
D. Veritti Italy
Back to Previous

Sign up to EURETINA

© EURETINA All rights reserved
Loading please wait